2026 Head of Translational Medicine Compensation Guide
Translational Medicine leaders bridge preclinical pharmacology and first-in-human trials. The function owns biomarker strategy, PK/PD modeling, and the science behind clinical proof of concept. Hiring intensity peaks 12-18 months before IND.
Direct Answer
What does a Head of Translational Medicine make in 2026?
Director of Translational Medicine at U.S. venture-backed biotech earns $320K-$420K base in 2026 with 22-28 percent target bonus and 0.15-0.40 percent equity. Senior Directors run $380K-$470K base. VP and Head of Translational Medicine commands $440K-$540K base with 25-32 percent bonus and 0.30-0.80 percent equity.
Compensation data is directional and may vary based on geography, company stage, industry, equity, bonus structure, and candidate experience. This guide is an educational resource, not a definitive compensation survey.
Compensation Bands
Base, bonus, and equity by level. All figures are 2026 U.S. directional ranges.
| Level | Base Salary | Bonus / OTE | Equity |
|---|---|---|---|
| Director Translational Medicine | $320K-$420K | 22-28% ($75K-$115K) | 0.15%-0.40% |
| Senior Director Translational | $380K-$470K | 25-30% ($100K-$140K) | 0.20%-0.55% |
| VP / Head of Translational | $440K-$540K | 28-35% ($130K-$190K) | 0.30%-0.80% |
Bonus Structure
Translational Medicine bonuses tie heavily to IND clearance and Phase 1 dose escalation milestones. Biomarker qualification, PK/PD model validation, and target engagement readouts trigger spot bonuses at most venture-backed biotechs.
Equity Structure
Translational equity grants at venture-backed biotech are among the highest in clinical functions because the role is strategy-defining for the program's clinical path. Senior Directors at preclinical biotech can secure equity comparable to Senior Director Discovery.
Geographic Comparisons
| Market | vs. Baseline | Commentary |
|---|---|---|
| Boston / Cambridge | 1.00x (baseline) | Deepest translational medicine pool. Sets the market. |
| San Francisco Bay Area | 1.00x-1.08x | Strong oncology and immunology translational talent. |
| San Diego | 0.92x-1.02x | Oncology cluster. Comparable equity, slightly lower cash. |
| Philadelphia / NJ | 0.92x-1.02x | Cell and gene therapy translational depth. |
| Remote (US) | 0.90x-1.00x | Common for Director+ roles given the analytical nature of the work. |
Hiring Market Commentary
- 1
Cell and gene therapy translational leadership is the tightest sub-specialty of the function in 2026.
- 2
AI-driven biomarker discovery platforms have created demand for translational leaders who can bridge ML and clinical pharmacology, a very small pool.
- 3
Pivotal-stage hiring of Translational VPs trails CMO hiring by 6-9 months in most venture-backed biotech timelines.
Talent Availability
Director-level supply is moderate. Senior Director and VP-level translational leaders with first-in-class clinical PoC experience in a specific modality are scarce.
Market Indicators
- ●Average time-to-hire VP Translational: 14-18 weeks
- ●Modality-specific premium: 10-15 percent base over generalist
- ●Pivotal trial PoC experience candidate pool: estimated <1,200 nationally
Recruits Lab Hiring Insights
Patterns we have observed across recent placements in this market.
Translational candidates who have authored a regulatory-relevant biomarker package close 2x faster in our 2024-2026 searches.
Founders who pair the Translational Medicine search with a Clinical Pharmacology hire signal program seriousness and convert candidates at higher rates.
Academic-to-industry transitions for senior translational leaders work best when paired with a senior industry second-in-command.
Frequently Asked Questions
When does a biotech hire its first Head of Translational Medicine?+
Most venture-backed biotechs hire a dedicated translational leader 6-12 months before IND, often co-timed with the Senior Director Clinical Development hire.
What is the difference between Translational Medicine and Clinical Pharmacology?+
Translational Medicine sets the biomarker and target engagement strategy across preclinical and clinical. Clinical Pharmacology focuses on PK, PD, and dose selection in human trials. The functions overlap at the leadership level.
Do Translational Medicine roles allow remote work?+
Yes. Roughly 60 percent of Director+ searches we run allow primary remote with travel to HQ and KOL meetings.
Compensation data is directional and may vary based on geography, company stage, industry, equity, bonus structure, and candidate experience. This guide is an educational resource, not a definitive compensation survey.
Related Guides & Authority Pages
Continue researching the markets adjacent to this role.
Work with Recruits Lab
Four ways to engage. Pick whichever matches where you are.
Schedule a Search Consultation
30-minute strategy review with a senior recruiter. Free, no commitment.
Get startedRequest Talent
Tell us about the role. We respond with a calibration call within 24 hours.
Get startedSubmit a Job
Send a job description. We confirm fit and quote a subscription or contingency engagement.
Get startedCandidate Representation
Senior candidates: get represented to our active hiring pipeline.
Get startedRelated Resources
Keep exploring Recruits Lab intelligence
Hand-picked salary guides, market reports, and recruiter pages related to this topic. Authored by Darren Nelson and the Recruits Lab team.
Market Reports
Recruiter Pages
Case Studies
Need Help Hiring?
Schedule a free 30-minute Hiring Strategy Review and walk away with a clear plan tailored to your roles.
- Hiring market insights
- Salary benchmarking
- Talent availability analysis
- Recruiting strategy recommendations